GSK-2593074A)
- CAS No.
- 1337531-06-2
- Chemical Name:
- GSK-2593074A)
- Synonyms
- GSK'074;GSK-2593074A);GSK2593074A (GSK'074;GSK2593074A,GSK-2593074A;GSK2593074A, 10 mM in DMSO;Ethanone, 1-[5-[4-amino-7-(1-methyl-1H-pyrazol-4-yl)thieno[3,2-c]pyridin-3-yl]-2,3-dihydro-1H-indol-1-yl]-2-phenyl-
- CBNumber:
- CB04844835
- Molecular Formula:
- C27H23N5OS
- Molecular Weight:
- 465.57
- MDL Number:
- MOL File:
- 1337531-06-2.mol
- MSDS File:
- SDS
- TDS File:
- TDS
GSK-2593074A) price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Biosynth | MDC53106 | GSK2593074A | 1337531-06-2 | 25mg | $1361.5 | 2026-06-04 | Buy |
| Biosynth | MDC53106 | GSK2593074A | 1337531-06-2 | 50mg | $1893.5 | 2026-06-04 | Buy |
| ChemScene | CS-0090385 | GSK2593074A 99.07% | 1337531-06-2 | 5mg | $379 | 2026-06-04 | Buy |
| ChemScene | CS-0090385 | GSK2593074A 99.07% | 1337531-06-2 | 10mg | $596 | 2026-06-04 | Buy |
| ChemScene | CS-0090385 | GSK2593074A 99.07% | 1337531-06-2 | 50mg | $1787 | 2026-06-04 | Buy |
GSK-2593074A) Chemical Properties, Uses, Production
Uses
GSK2593074A (GSK’074) is a necroptosis inhibitor with dual targeting ability to both RIP1 and RIP3[1].
in vivo
GSK2593074A (GSK’074; 0.93 mg/kg/day; i.p. injection; 14 or 28 days) is administrated to Apoe-/- mice immediately following pump implantation. Compared to the DMSO group, GSK2593074A-treated mice show significantly alleviated aneurysm formation, reflected by a much smaller aortic dilatation (DMSO 85.39±15.76% vs GSK2593074A 36.28±5.76%; P<0.05) as well as a reduced abdominal aortic aneurysm (AAA) incidence (from 83.3 to 16.7%). GSK2593074A significantly decreases the extent of aortic expansion (DMSO 66.06±9.17% vs GSK2593074A 27.36±8.25%; P<0.05) [1].
| Animal Model: | Apoe-/- female mice (9-10 months)[1] |
| Dosage: | 0.93mg/kg/day; 200μL |
| Administration: | Daily i.p. injection; 14 or 28 days |
| Result: | Inhibited aneurysm formation in mouse models of aneurysms. |
References
[1] Zhou T, et al. Identification of a novel class of RIP1/RIP3 dual inhibitors that impede cell death and inflammation in mouse abdominal aortic aneurysm models. Cell Death Dis. 2019 Mar 6;10(3):226. DOI:10.1038/s41419-019-1468-6
GSK-2593074A) Preparation Products And Raw materials
Raw materials
Preparation Products
GSK-2593074A) Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| BOC Sciences | 1-631-485-4226; 16314854226 | info@bocsci.com | United States | 9920 | 65 |
| Shanghai YuanYe Biotechnology Co., Ltd. | 15026964105 | 2881489226@qq.com | China | 89667 | 60 |
| Fan De(Beijing) Biotechnology Co., Ltd. | 15911056312 | liming@bio-fount.com | China | 9718 | 58 |
| TargetMol Chemicals Inc. | +1-781-999-5354; +1-00000000000 | marketing@targetmol.com | United States | 32431 | 58 |
| InvivoChem | +1-708-310-1919 +1-13798911105 | sales@invivochem.cn | United States | 6378 | 58 |
| HANGZHOU CLAP TECHNOLOGY CO.,LTD | 86-571-88216897,88216896 13588875226 | sales@hzclap.com | CHINA | 6288 | 58 |
| ChemeGen(Shanghai) Biotechnology Co.,Ltd. | 18818260767 | sales@chemegen.com | China | 11123 | 58 |
| Shanghai hongqu biomedical technology co. LTD | 88888888888 | hongquchem@qq.com | China | 5123 | 58 |
| cjbscvictory | 13348960310 13348960310 | 3003867561@qq.com | China | 10233 | 58 |
| SINO High Goal Chemical Technology Co., Ltd. | 021-57646680 18306277365 | guoxin@chembiobanksh.com | China | 2819 | 58 |
View Latest Price from GSK-2593074A) manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
![]() |
2026-07-27 | GSK2593074A
1337531-06-2
|
$116.00-455.00 | 99.99% | 10g | TargetMol Chemicals Inc. | ||
![]() |
2026-07-27 | GSK2593074A
1337531-06-2
|
$116.00-455.00 | 99.99% | 10g | TargetMol Chemicals Inc. |
-

- GSK2593074A
1337531-06-2
- $116.00-455.00
- 99.99%
- TargetMol Chemicals Inc.
-

- GSK2593074A
1337531-06-2
- $116.00-455.00
- 99.99%
- TargetMol Chemicals Inc.




